Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Topotecan plus whole-brain radiotherapy in brain metastases
2005-002499-14Phase 2Active
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan in brain metastases, sponsored by Grupo Español de Investigación en Neurooncología. Primary endpoint: Objective radiologic response rate at 30 days after completion of chemoradiotherapy. Started Jul 2005; status: active.
02
Drugs
topotecan
03
Conditions
brain metastases
Beyond the preview
Go deeper on 2005-002499-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002499-14.